The present invention concerns non-human transgenic animals as model study
for human pathologies, being transgenic for having altered melusin
expression. The non-human transgenic animals are to be used as models to
study heart pathologies and provide therapies thereof, wherein the heart
pathologies are heart failure, and in particular diluted cardiomyopathy.